Loading...
Market
Chinese company found guilty in U.S. fentanyl precursor case by end of 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official court rulings or announcements from the U.S. Department of Justice
Story
U.S. Indicts Chinese Company for Fentanyl and Xylazine Precursor Distribution; $3 Million Worth of Chemicals Air-Shipped to New Jersey for $3,600
Nov 16, 2024, 05:18 PM
The U.S. Department of Justice announced the indictment of a Chinese chemical company, its director, and three senior employees for allegedly manufacturing and distributing precursors for fentanyl and xylazine. The indictment follows claims that the company spent approximately a decade distributing chemicals used to produce these lethal drugs. Additionally, reports surfaced indicating that a major news organization was able to purchase chemicals necessary for producing $3 million worth of fentanyl for only $3,600, with the ingredients air-shipped from China to New Jersey. This situation raises concerns about the ease of access to these dangerous substances and the implications for drug enforcement efforts in the U.S.
View original story
Similar markets
Additional bilateral agreements with China • 25%
Increased domestic enforcement and regulation • 25%
No significant policy changes • 25%
Other responses (e.g., public health initiatives, international cooperation) • 25%
Further regulation of additional chemicals • 25%
Increased enforcement of current regulations • 25%
No additional regulatory actions • 25%
Other actions (e.g., international cooperation, public health campaigns) • 25%
Yes • 50%
No • 50%
Joint task force creation • 25%
Information sharing agreement • 25%
No agreement reached • 25%
Other forms of cooperation • 25%
Yes • 50%
No • 50%
Significant decrease in fentanyl-related deaths and seizures • 25%
Moderate decrease in fentanyl-related deaths and seizures • 25%
No significant change in fentanyl-related deaths and seizures • 25%
Increase in fentanyl-related deaths and seizures • 25%
Increased tariffs • 25%
Decreased tariffs • 25%
New trade agreements • 25%
Status quo • 25%